Fleming Michael 4

4 · Merck & Co., Inc. · Filed May 7, 2019

Form 4

Period: 2019-05-03

SVP Chief Ethics & Com Officer

Transactions

Exercise/Conversion
Common Stock
2019-05-04+692→ 2,045.829 total
Award
Stock Option (right to buy)
2019-05-03+11,291→ 11,291 total
Exercise: $80.00From: 2020-05-03Exp: 2029-05-02→ Common Stock (11,291 underlying)
Tax Payment
Common Stock
2019-05-04$80.00/sh−238$19,040→ 1,807.829 total
Exercise/Conversion
Restricted Stock Unit
2019-05-04$80.00/sh−692$55,360→ 1,386 total
From: 2019-05-04Exp: 2021-05-04→ Common Stock (692 underlying)
Award
Restricted Stock Unit
2019-05-03+1,500→ 1,500 total
From: 2020-05-03Exp: 2022-05-03→ Common Stock (1,500 underlying)

Footnotes (5)

[F1]Holdings include shares acquired in dividend reinvestment transactions.
[F2]The option vests and becomes exercisable in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.
[F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
[F4]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.
[F5]These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/3/2020, 5/3/2021 and 5/3/2022.

Documents

1 file